|
|
||||||||
Vol. 83, Issue 6, 2167-2168, December 1997
The following is the abstract of the article discussed in the subsequent letter:
Batterham, Alan M., Keith Tolfrey, and Keith P. George. Nevill's explanation of Kleiber's 0.75 mass exponent: an
artifact of collinearity problems in least squares models? J. Appl. Physiol. 82(2): 693-697, 1997.
Intraspecific
allometric modeling (Y = a · massb,
where Y is the physiological dependent variable and a
is the proportionality coefficient) of peak oxygen uptake
(
O2peak) has frequently
revealed a mass exponent (b) greater than that predicted from
dimensionality theory, approximating Kleiber's 3/4 exponent for basal
metabolic rate. Nevill (J. Appl. Physiol. 77: 2870-2873,
1994) proposed an explanation and a method that restores the inflated
exponent to the anticipated 2/3. In human subjects, the method involves
the addition of "stature" as a continuous predictor variable in a
multiple log-linear regression model: ln Y = ln a + c · ln stature + b · ln mass + ln
, where c is the general body size exponent and
is
the error term. It is likely that serious collinearity confounds may
adversely affect the reliability and validity of the model. The aim of
this study was to critically examine Nevill's method in modeling
O2peak in prepubertal,
teenage, and adult men. A mean exponent of 0.81 (95% confidence
interval, 0.65-0.97) was found when scaling by mass alone.
Nevill's method reduced the mean mass exponent to 0.67 (95%
confidence interval, 0.44-0.9). However, variance inflation factors and tolerance for the log-transformed stature and mass variables exceeded published criteria for severe collinearity. Principal components analysis also diagnosed severe collinearity in two
principal components, with condition indexes >30 and variance decomposition proportions exceeding 50% for two regression
coefficients. The derived exponents may thus be numerically inaccurate
and unstable. In conclusion, the restoration of the mean mass exponent
to the anticipated 2/3 may be a fortuitous statistical artifact.
Collinearity: A Function of the Sample Size, Range, and Similarity of Observations
To the Editor: I wish to express my surprise that the Journal of Applied Physiology decided to publish the paper by Batterham et al. (2) entitled "Nevill's explanation of Kleiber's 0.75 mass exponent: an artifact of collinearity problems in least squares models?". Based on a sample size of n = 75 (prepubertal, teenage, and adult males), the authors examined how peak oxygen uptake (
O2; 1 min)
might be scaled for differences in body size. Although the study
confirms the work of Nevill (8) that an inflated mass exponent occurs
(0.81) if mass alone is used to scale peak
O2, the authors are
concerned that by including stature in addition to mass as a second
covariate, the result may lead to collinearity.
The authors' concerns are unfounded. There are numerous examples in
the literature when both height and weight have been used to predict
various dependent variables, e.g., body fat (1, 5, 7), blood pressure
(6, 9), and the dependent variable of interest, peak
O2 (3, 8, 10, and unpublished
observations of Nevill and Holder). In all these papers, the
contributions of height and weight were both significant, and no
collinearity was reported. For example, when blood pressure was used as
the dependent variable (see Refs. 6, 9), the contributions from both
height and weight provided highly significant exponents
(P < 0.0001) but with opposite signs, i.e., predicting a
stature-adjusted weight index (approximately the body mass index ratio)
as a measure of "overweight."
There also exists overwhelming evidence that both height and weight are
necessary when predicting peak
O2, i.e., taller subjects have significantly greater peak
O2, having already controlled for differences in body weight (3, 8, 10, and unpublished observations of Nevill and Holder). The sample sizes used in these studies were as follows; Baxter Jones et al. (3), n = 453 young elite athletes (231 men and 222 women); Welsman et al. (10), n = 156 school children (73 boys and 83 girls), and Nevill and Holder
(unpublished observations), n = 1,732 adults, age 16 yr and
over (852 men and 880 women). The strength of collinearity observed in Batterham et al. (2) (sample size n = 75) may be a function of the sample size and the range and similarity of observations (4), a problem more evident in Batterham et al. (2) than
in the studies of Baxter-Jones et al. (3), Nevill (8), Welsman et al.
(10), and Nevill and Holder (unpublished observations).
Nevill (8) suggested that the significant contribution of height in
addition to body weight might be explained by a disproportionate increase in muscle mass with body size. However, based on the unpublished findings of Nevill and Holder, an alternative explanation now becomes apparent. The best model to predict maximal
O2 incorporated a
significant contribution from forced vital capacity (FVC; also known to
be predominately stature related) as well as body mass, whereas the
height term became redundant, no longer making a significant contribution to the regression model. Clearly, on the basis of these
findings, the apparent advantage of being taller would appear to be
more accurately explained by the subjects' greater FVC. In effect, the
significant contribution of the height term, found in the earlier
studies (3, 8, 10), would appear to have been inadvertently providing
an estimate of the subjects' FVC. This was an unexpected result,
although not entirely surprising. Taking the analogy with the motor car
engine, we would expect a greater performance (maximum speed and power
output) from an engine with a greater cubic capacity, so perhaps we
might also expect a greater maximum
O2 from a subject with a
greater (forced) vital capacity.
| 1. | Abdel-Malek, A. K., D. Mukherjee, and A. F. Roche. A method of constructing an index of obesity. Human Biol. 57: 415-430, 1985[Medline]. |
| 2. |
Batterham, A. M.,
K. Tolfrey,
and
K. P. George.
Nevill's explanation of Kleiber's 0.75 mass exponent: an artifact of collinearity problems in least squares models?
J. Appl. Physiol.
82:
693-697,
1997 |
| 3. |
Baxter-Jones, A.,
H. Goldstein,
and
P. Helms.
The development of aerobic power in young athletes.
J. Appl. Physiol.
75:
1160-1167,
1993 |
| 4. | Belsley, D. A., E. Kuh, and R. E. Welsch. Regression Diagnostic: Identifying Influential Data and Sources of Collinearity. New York: Wiley, 1980. |
| 5. | Benn, R. T. Some mathematical properties of weight-for-height indices used as measures of adiposity. Br. J. Prev. Soc. Med. 25: 42-50, 1971[Medline]. |
| 6. | Fentem, P. H., A. M. Nevill, and R. H. Holder. Physical activity and arterial blood pressure. Med. Sci. Sport Exerc. 28: 112S, 1996. |
| 7. | Garrow, J. S., and J. Webster. Quetelet's index (W/H2) as a measure of fatness. Int. J. Obes. 9: 147-153, 1985[Medline]. |
| 8. |
Nevill, A. M.
The need to scale for differences in body size and mass: an explanation of Kleiber's 0.75 mass exponent.
J. Appl Physiol.
77:
2870-2873,
1994 |
| 9. | Nevill, A. M., R. L. Holder, P. H. Fentem, M. Rayson, T. Marshall, C. B. Cooke, and W. Tuxworth. Modelling the associations of BMI, physical activity and diet with arterial blood pressure; some results from the Allied Dunbar national fitness survey. Ann. Human Biol. 24: 229-247, 1997[Medline]. |
| 10. |
Welsman, J. R.,
N. Armstrong,
A. M. Nevill,
E. M. Winter,
and
B. J. Kirby.
Scaling peak O2 for differences in body size.
Med. Sci. Sports Exerc.
28:
259-265,
1996[Medline].
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |